Why the Route Choice Matters

The conformity assessment route you choose determines what your Notified Body will audit, what documentation you must prepare, and how ongoing compliance surveillance works post-certification. The choice also affects cost, timeline, and operational flexibility. Choosing the wrong route — or switching routes mid-process — adds time and cost. The route must be documented in your Declaration of Conformity and your Technical File, and your Notified Body must be contracted for the specific route you are applying under.

Annex IX: QMS + Technical Documentation Assessment

Annex IX is the most common route for Class IIa, IIb, and Class III devices. It has two components: Chapter I (QMS Assessment) and Chapter II (Technical Documentation Assessment). Under Chapter I, the Notified Body audits your Quality Management System against ISO 13485 and MDR QMS requirements — verifying that your design, development, production, and post-market processes meet regulatory requirements. Under Chapter II, the Notified Body reviews the Technical Documentation for a representative sample of devices. For Class III devices and certain Class IIb implantable devices, a full Technical Documentation assessment is required for each device, not just a sample. Annex IX is preferred by most manufacturers because it creates a framework that covers multiple devices under a single QMS assessment.

Annex XI Part A: Type Examination

Annex XI Part A (Type Examination) involves the Notified Body examining and testing a physical representative sample (the 'type') of the device against all applicable MDR requirements, including safety, performance, and labelling. This route does not involve a QMS audit — it focuses on the device itself. Type Examination is required for certain Class III and Class IIb devices. Part A is often used in combination with Annex XI Part B (production quality assurance) rather than as a standalone route.

Annex XI Part B: Production Quality Assurance

Annex XI Part B covers production quality assurance — the Notified Body audits the manufacturer's production processes and quality controls rather than the full QMS. This route is typically combined with Annex XI Part A (Type Examination) to create a full conformity assessment pathway. Part B is less common than Annex IX and is typically used by manufacturers who have already undergone type examination and want a focused production audit rather than a full QMS assessment.

Which Route is Right for Your Device?

For most Turkish medical device manufacturers, Annex IX (QMS + Technical Documentation) is the most practical and strategically sound route because: (1) A single QMS certificate covers all devices manufactured under that QMS, reducing per-device certification costs, (2) The quality management framework created for MDR QMS compliance is also aligned with ISO 13485 and FDA QSR requirements — creating multi-market regulatory value, (3) Post-certification surveillance is conducted through annual QMS audits rather than repeated product testing. Annex XI Part A + Part B may be required or preferred for specific complex or novel devices where the Notified Body wants product-level testing evidence before issuing a certificate.

Class I Devices: Self-Declaration

Class I devices (non-sterile, non-measuring, non-reusable surgical instruments) follow a self-declaration route under MDR — the manufacturer declares conformity without Notified Body involvement. However, Class Is (sterile), Class Im (measuring), and Class Ir (reusable surgical instruments) require limited Notified Body involvement for the sterility, measuring function, or reprocessing aspects respectively. Class I self-declaration requires: a complete Technical File, a Declaration of Conformity, a Quality Management System adequate for the device's complexity, and a registered EU Authorised Representative.

Practical Timeline Comparison

Annex IX (QMS + Technical Documentation) for a Class IIa device: typically 6–12 months from complete application submission for straightforward products with an experienced manufacturer. Class IIb devices: 9–18 months. Class III devices: 12–24+ months. Notified Body capacity constraints mean that current timelines across the EU are at the longer end of these ranges. Turkish manufacturers should begin Notified Body discussions 3–6 months before they plan to submit an application, as pre-application meetings and contract negotiation add time before the formal clock starts.

Conclusion

The conformity assessment route decision should be made with your regulatory affairs consultant and your chosen Notified Body as early as possible in the MDR certification planning process. For most Turkish manufacturers, Annex IX provides the most scalable, cost-effective framework for multi-device certification under a single QMS assessment. Understanding the route before you build your technical file ensures that your documentation is structured to meet the specific requirements of your chosen assessment pathway.